FELIQS plans to conduct a Phase 1b/2 study of FLQ-101 (tROPhy-1 study) both in the US and Japan in the first quarter of 2025.

Metabolic dysfunction-associated steatohepatitis, or MASH, is a kind of chronic liver inflammation and scarring caused by ...

While babies born at full term after a gestation period of nine months weigh around 2.5 to 4 kg, this one was weak with ...

Oak Hill Bio and Chiesi Group have enrolled the first European patient in a Phase IIb clinical study for their collaborative ...

Oak Hill Bio, Chiesi announce first European patient enrolled in phase 2b study of OHB-607 for prevention of BPD in premature infants: Parma, Italy Tuesday, November 5, 2024, 14:0 ...

FLQ-101 is still an investigational medicine and has not yet been approved by regulatory authorities. "FDA grants fast track ...

A woman who started a prematurity awareness day after her twin grandchildren were born 15 weeks early is set to host the event for the fifth time ...

A woman who started a prematurity awareness day after her twin grandchildren were born 15 weeks early is set to host the event for the fifth time ...

A woman who started a prematurity awareness day after her twin grandchildren were born 15 weeks early is set to host the ...

El Mirage organizes a Community Blood Drive on November 12, 2024, supporting premature babies during National Prematurity ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

As neonatologists, we care for the most fragile newborns, some no larger than the size of their parent’s hand. These preterm newborns face many medical challenges.